In Cannabis sativa L. the presence of delta 9-tetrahydrocannabinolic acid (THCA) above
legal limit is a challenging issue that still restricts the industrial exploitation of this promising …

Cannabis (Cannabis sativa L.) has a rich history of human use, and the therapeutic
importance of compounds produced by this species is recognized by the medical …

A major challenge in utilizing cannabis (Cannabis sativa L.) for modern medicine is the lack
of standardization throughout the plant of cannabinoids, the unique therapeutic secondary …

Cannabis sativa L. is the utmost consumed, grown, and produced illicit drug worldwide. The
psychotropic activity of the component (-)-trans-∆ 9-tetrahydrocannabinol (∆ 9-THC) …

Growing evidence underscores the role of nutrients and fertigation systems in soilless
production, influencing medicinal cannabis biomass and secondary metabolite content. This …

Abstract Introduction Medical uses of Cannabis sativa L. have gained interest in recent
decades, which highlights the need for defining appropriate quality specifications for …

Cannabis sativa is a source of food, fiber and specialized metabolites such as cannabinoids,
with psychoactive and pharmacological effects. Due to its expanding and increasingly …

Cannabis sativa L., subsp. ruderalis Janish.,'Finola'is a dioecious cultivar of Finnish origin.
This cultivar is very interesting because its cultivation cycle lasts less than 3 months. The aim …

In order to complete a genetic model for the inheritance of chemotype in Cannabis, this
paper explores the regulation of the propyl-/pentyl cannabinoid ratio. Plants almost pure in …

Cannabis sativa L. plants produce a diverse array of secondary metabolites. Cannabis cell
cultures were treated with jasmonic acid (JA) and pectin as elicitors to evaluate their effect …